Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$80,411,090
+$72,404,891 QoQ
Shares Held
296,228
+640.0% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
4.51%
of 13F equity value
Holder Rank
#70
of 844 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Capital Impact Advisors, LLC holds $116,655,700 across 2 Diagnostics & Research names. NTRA ranks #1 (68.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
296,228 | $80,411,090 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
68,439 | $36,244,610 |
All Filings in NTRA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,411,090 | 296,228 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,006,199 | 40,033 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,907,914 | 178,567 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,472,547 | 65,059 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,249,340 | 48,830 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $6,686,006 | 47,281 | Shares | Sole | 2025-05-20 | |
| 2023-06-30 | $320,280 | 6,582 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $340,615 | 6,135 | Shares | Sole | 2023-05-23 | |
| 2021-09-30 | $4,911,049 | 44,069 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,443,904 | 39,143 | Shares | Sole | 2021-08-17 | |
| 2020-12-31 | $4,976,000 | 50,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,056,800 | 70,000 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||